CRVO
CervoMed Inc.Marquee-fund ownership over time
This quarter's activity
New positions opened
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Renaissance Technologies re-entered | Q3 2024(8Q snapshot) | 7Q | $11 | $3.04 | -73% |
| Millennium Management re-entered | Q4 2024(8Q snapshot) | 6Q | $11 | $3.04 | -72% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Citadel Advisors 2× in & out | Q4 2025 | Q2 2026 | → $3.44 | -55% |
| Two Sigma Investments | Q4 2025 | Q2 2026 | → $3.44 | -55% |
| AQR Capital Management | Q2 2025 | Q4 2025 | → $7.68 | -11% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at CervoMed Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Feb 13, 2026 — the most recent Form 4 on file — not from today.
- Form 40001437749-26-004168Feb 13, 2026
- Form 40001437749-26-004167Feb 13, 2026
- Form 40001437749-26-004166Feb 13, 2026
- Form 40001437749-26-004165Feb 13, 2026
- Form 40001437749-26-004164Feb 13, 2026
- Form 40001437749-26-004162Feb 13, 2026
- Form 40001437749-25-037054Dec 5, 2025
- Form 40001437749-25-035655Nov 19, 2025
- Form 40001437749-25-035654Nov 19, 2025
- Form 40001437749-25-035653Nov 19, 2025
- Form 40001437749-25-035652Nov 19, 2025
- Form 40001437749-25-035310Nov 17, 2025
- Form 40001437749-25-035309Nov 17, 2025
- Form 40001437749-25-035308Nov 17, 2025
- Form 40001437749-25-034640Nov 13, 2025
Fundamentals
XBRL · CervoMed Inc.Annual figures sourced directly from CervoMed Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for CervoMed Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KFORM 8-KJun 9, 2026
- 8-KFORM 8-KMay 18, 2026
- 10-QFORM 10-QMay 15, 2026
- DEF 14AFORM DEF 14AApr 30, 2026
- 8-KFORM 8-KApr 22, 2026
- 8-KFORM 8-KApr 7, 2026
- 8-KFORM 8-KMar 23, 2026
- 8-KFORM 8-KMar 19, 2026
- 8-KFORM 8-KMar 17, 2026
- 10-KFORM 10-KMar 13, 2026
- 8-KFORM 8-KMar 4, 2026
- 8-KFORM 8-KFeb 18, 2026
- 8-KFORM 8-KJan 8, 2026
- 8-KFORM 8-KDec 5, 2025
- 8-KFORM 8-KNov 10, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Renaissance Technologies | Q2 2026 | open | $3.76 | $3.04 | -19% |
| Citadel Advisors | Q4 2025 | Q2 2026 | $7.68 | $3.44 | -55% |
| Two Sigma Investments | Q4 2025 | Q2 2026 | $7.68 | $3.44 | -55% |
| Millennium Management | Q3 2025 | open | $10 | $3.04 | -70% |
| AQR Capital Management | Q2 2025 | Q4 2025 | $8.64 | $7.68 | -11% |
| Citadel Advisors | Q4 2024 | Q2 2025 | $11 | $8.64 | -21% |
| Millennium Management | Q4 2024 | Q2 2025 | $11 | $8.64 | -21% |
| Renaissance Technologies | Q3 2024 | Q1 2025 | $11 | $2.19 | -81% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.